Portfolio company
Nkarta
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops engineered natural killer cell therapies to treat patients with cancer and autoimmune diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Artiva Biotherapeutics
The company develops allogeneic natural killer cell therapies for patients with autoimmune diseases and cancer.
Artiva
Artiva Biotherapeutics develops off-the-shelf natural killer cell therapies to treat patients with autoimmune diseases and cancers.
ARTV
This clinical-stage biotechnology company develops natural killer cell therapies for patients with autoimmune diseases and cancers.
Modulus Therapeutics
This company develops engineered NK-cell therapies for autoimmune disease patients using a generative design and rapid prototyping platform.
Arcellx
This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.
NKIO
This company develops natural killer cell therapies and small molecule medicines to treat solid tumours for patients with cancer and inflammatory diseases.
Autolus Therapeutics
This company develops programmed T-cell therapies for patients with cancer and autoimmune diseases.
Century Therapeutics
This biotechnology company develops induced pluripotent stem cell-derived therapies to treat patients with cancer and autoimmune diseases.
